Status:
COMPLETED
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
Lead Sponsor:
Stanford University
Conditions:
Chorioamnionitis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
Eligibility Criteria
Inclusion
- \- clinical diagnosis of chorioamnionitis
Exclusion
- \- maternal renal disease, intrauterine fetal death, allergy to gentamicin
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00185991
Start Date
June 1 2004
End Date
February 1 2010
Last Update
June 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305